JSKN033

DRUG2 trials

Sponsors

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Conditions

Advanced Malignant TumorsCervical Cancer

Phase 1

JSKN033 in Chinese Subjects with Advanced Malignant Tumors

Not yet recruitingNCT06770881

Jiangsu Alphamab Biopharmaceuticals Co., LtdAdvanced Malignant Tumors

Start: 2025-01-15End: 2027-12-31Target: 430Updated: 2025-01-13

Phase 2

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Not yet recruitingNCT07497074

Jiangsu Alphamab Biopharmaceuticals Co., LtdCervical Cancer

Start: 2026-04-01End: 2028-06-01Target: 78Updated: 2026-03-27